This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Best Leveraged ETF Areas of Last Week
by Sanghamitra Saha
If investors can identify the trending investing area amid all the coronavirus chaos, they can easily take a leveraged position on that and beat the broader market.
5 Top-Performing Leveraged ETFs of November
by Sweta Killa
Inside the best five best leveraged ETFs of November.
Leveraged ETFs That Are Up 25% Plus at Halfway Q4
by Sweta Killa
We have highlighted a few leveraged equity ETFs that have piled up more than 25% returns so far in the fourth quarter and could continue to be investors' darlings.
Best Leveraged ETF Areas of Last Week
by Sanghamitra Saha
These leveraged ETFs posted solid gains last week.
6 Best Performing Leveraged ETFs of Q1
by Sweta Killa
We have highlighted six leveraged equity ETFs that have piled up more than 50% returns in the first quarter.
The Zacks Analyst Blog Highlights: Direxion Daily S&P, Direxion Daily Regional Banks, Direxion Daily Aerospace, Direxion Daily Industrials and Direxion Daily Small Cap
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Direxion Daily S&P, Direxion Daily Regional Banks, Direxion Daily Aerospace, Direxion Daily Industrials and Direxion Daily Small Cap
Leveraged ETFs That Soared More Than 50% in February
by Sweta Killa
We have highlighted some leveraged equity ETFs that have piled up more than 50% returns in February.
Will Weak Retail Sales Keep ETF Bulls at Bay?
by Sweta Killa
The worst drop in retail sales in nine years could create some panic in the stock market but can't keep the bulls away for long.
Wall Street Caps Best Month in Decades: 6 Top Leveraged ETFs
by Sweta Killa
We have highlighted six leveraged ETFs that have piled up exceptional returns in the first month of 2019 given that Wall Street made a sharp turnaround, posting the best month in many decades.
9 Leveraged ETFs That Soared More Than 25% to Start 2019
by Sweta Killa
We have highlighted nine ETFs that have piled up exceptional returns to start 2019 and will continue to be investors' darlings provided the sentiments remain the same.
Best August for US Stocks in 4 Years: 5 Top Leveraged ETFs
by Sweta Killa
The month of August was strong for the U.S. stock market that has resulted in a strong demand for leveraged ETFs.
7 Top Performing Leveraged ETFs of May
by Sweta Killa
The frequent change in sentiments raised the appeal of leveraged ETFs as investors sought to register big gains in a short span.
5 Best-Performing Leveraged ETFs of January
by Sweta Killa
Demand for leveraged ETFs is growing as investors seek to register big gains in a short span.
The Zacks Analyst Blog Highlights: NAIL, CWEB, LABU, SOXL and EDC
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NAIL, CWEB, LABU, SOXL and EDC
7 Top-Performing Leveraged ETFs of 2017
by Sweta Killa
The stock market bullishness has resulted in huge demand for leveraged ETFs as investors seek to register big gains in a short span.
New Pharma ETF PILL : What Investors Need to Know
by Sanghamitra Saha
Inside the pros and cons of the pharma sector and chances of outperformance of the just-launched fund PILL.
Leveraged ETFs to Play the Second-Largest Bull Market
by Sweta Killa
Braving all economic and political challenges, the U.S. stock market is scaling new highs, indicating that the second-largest bull run still has legs.
The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bull 3X ETF, Direxion Daily South Korea Bull 3X ETF, Direxion Daily CSI China Internet Bull 2X Shares, Direxion Daily Hmbldrs&Supls Bull 3X ETF and Direxion Daily MSCI India Bull 3
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bull 3X ETF, Direxion Daily South Korea Bull 3X ETF, Direxion Daily CSI China Internet Bull 2X Shares, Direxion Daily Hmbldrs&Supls Bull 3X ETF and Direxion Daily MSCI India Bull 3x ETF
Best Leveraged ETFs of First Half of 2017
by Sanghamitra Saha
Inside the top five leveraged ETFs of the first half of 2017.
5 Reasons Why Biotech ETFs are Soaring
by Sanghamitra Saha
Reasons that propelled the biotech space and the related ETFs higher.
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data
by Sanghamitra Saha
Clovis Oncology clinical trial data has given a boost to the biotech sector and put these stocks and ETFs in focus.
7 Best Leveraged ETFs So Far in 2017
by Sweta Killa
Amid bouts of volatility, global stocks hit all-time highs on hopes of reflation trade and a slew of robust global data on export, employment and inflation.
Leveraged ETFs: How Are They Built and What's Hot Now?
by Eric Dutram
Do you know how leveraged and inverse ETFs work? Find out in this edition of the Dutram Report, where we discuss that topic, and some of the hottest funds in the leveraged and inverse ETF world right now.
10 Leveraged/Inverse ETFs with Over 30% Surge in November
by Sweta Killa
Inside the best performing Leveraged/Inverse ETFs of November.
Bull Market Here to Stay: 10 ETF Ways to Play
by Sweta Killa
The bull trend in the stocks will likely to continue in the coming months assuming that the Trump rally will stretch and seasonality boom.